Medium materiality6/10
Agios Pharmaceuticals price target lowered to $37 from $39 at Truist
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist trims AGIO PT to $37 from $39; current price $31.55.
- PT: $37; Price: $31.55; Upside remains but reduced.
Key facts
- 01
Target: $37
- 02
Posted price: $31.55
- 03
Analyst firm: Truist Financial
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.